South Carolina Cannabis Business Loans & Financing
South Carolina does not yet have a legal cannabis market. As of early 2026, the state has no medical cannabis program, no commercial cannabis licenses, and no legal dispensaries. Cannabis possession remains a criminal offense, and the state is one of only a handful nationwide without any form of regulated medical access beyond a narrow exception for low-THC CBD oil under Julian's Law (2014), which is limited to epilepsy patients.
That said, the legislative landscape is shifting. The South Carolina Compassionate Care Act (S. 53) has been introduced repeatedly and has passed the state Senate more than once, most recently in 2024. The 2025-2026 session version, sponsored by Sen. Tom Davis (R-Beaufort) and Sen. Stephen Goldfinch (R-Georgetown), was referred to the Senate Committee on Medical Affairs in January 2025.
The legislature adjourned in May 2025 without holding hearings on any cannabis bill and returns in January 2026 for the second half of its session. Public polling shows 83% of registered South Carolina voters support medical cannabis legalization, including 74% of Republicans.
When South Carolina's market opens, licensed operators will need financing partners who understand how cannabis businesses actually work. FundCanna is watching this market closely and is prepared to serve South Carolina cannabis business loans from the moment the state begins issuing licenses.
Applying for Cannabis Funding in South Carolina has never been easier.
Fill out the form below and have access to the capital you need in as little as 24 hours.
3 easy steps
Get access to the funding your Cannabis Business needs. FAST
Where South Carolina Stands
South Carolina's path to a legal cannabis market has been defined by steady Senate progress and repeated House inaction. Understanding where things stand is important for anyone positioning to enter this market.
The Compassionate Care Act has been the primary legislative vehicle for over a decade. Sen. Davis first authored Julian's Law in 2014, providing limited CBD access for epilepsy patients. He has since championed increasingly detailed medical cannabis legislation. In 2022, a version of the bill (S. 150) passed the Senate 28-15 but was killed in the House over a procedural challenge related to a tax provision. Revenue-raising bills must originate in the South Carolina House, and the inclusion of a cannabis-specific tax gave opponents an opening to block it.
In 2024, a revised version (S. 423) again passed the Senate on a 24-19 vote, then died in the House Medical, Military, Public and Municipal Affairs Committee without receiving a floor vote. The 2025 version (S. 53) removed the cannabis-specific tax provision entirely, eliminating the procedural vulnerability that sank earlier versions. Cannabis would simply be taxed at the same rate as non-prescription medications under existing state tax law. Despite this fix, the legislature adjourned in May 2025 without scheduling hearings.
The second half of the 2025-2026 legislative session begins in January 2026. Whether the Compassionate Care Act advances through the House remains the central question. The Senate has demonstrated consistent bipartisan support. The House has been the obstacle.
Meanwhile, the hemp-derived cannabinoid market in South Carolina is growing rapidly. THC beverages and other hemp-derived products are widely available under the state's federally aligned hemp framework. Multiple bills filed in 2025, including H. 137 and H. 3935, would create a state licensing system, testing requirements, and age restrictions for hemp-derived cannabinoid products. This parallel regulatory activity signals that South Carolina lawmakers are engaging with cannabinoid commerce, even as the medical cannabis debate continues.
What the Compassionate Care Act Would Create
If enacted, S. 53 would establish a tightly regulated medical-only cannabis program. The structure proposed is conservative by national standards, but it would create a real commercial market with clear license categories and defined supply chain roles.
What the Compassionate Care Act Would Create
If enacted, S. 53 would establish a tightly regulated medical-only cannabis program. The structure proposed is conservative by national standards, but it would create a real commercial market with clear license categories and defined supply chain roles.
Proposed License Structure
The bill calls for a merit-based application process administered by the state Department of Public Health, with the following license caps:
Cultivation Centers
15 licenses statewide. Indoor-only facilities, each capped at two acres of canopy (87,120 square feet), including any vertically tiered or shelving systems. Cultivation centers would supply processing facilities, therapeutic cannabis pharmacies, testing labs, and research facilities.
Processing Facilities
30 licenses statewide. These operations would manufacture cannabis products including oils, edibles, salves, and other non-smokable forms. Smoking cannabis would remain illegal under the bill, so all flower must be processed into approved product forms before reaching patients.
Therapeutic Cannabis Pharmacies
Approximately 65 licenses, calculated as one pharmacy for every 20 existing pharmacies in the state. These are the retail-facing establishments, overseen by a licensed pharmacist-in-charge who must be physically on premises during dispensing hours. No county may have more than three. The Board of Pharmacy would regulate operations alongside the Department of Public Health.
Independent Testing Laboratories
5 licenses for facilities conducting cannabinoid profiling, pesticide testing, and contaminant screening.
Integrated Operators
The bill also provides for vertically integrated licenses allowing a single entity to hold cultivation, processing, and pharmacy licenses. The number of integrated licenses would be determined by a commission within the Department of Public Health.
Transporters
4 licenses for licensed cannabis transport operations.
Key Market Parameters
The program would be medical-only, requiring patients to have a qualifying condition, a physician certification, and a registration card. Qualifying conditions include cancer, multiple sclerosis, epilepsy, PTSD, Crohn's disease, sickle cell anemia, and several other debilitating diagnoses. Patients would be limited to a 14-day supply. No smoking, no home cultivation, no raw flower. All products must be processed, tested, and dispensed through the licensed pharmacy model.
Local control is built into the bill. Municipalities would have the authority to prohibit medical cannabis establishments in their jurisdictions or to regulate zoning, hours, and operational parameters. This means market access would vary by county and city, similar to how alcohol regulation works in many Southern states.
The program includes a five-year sunset provision. It would automatically expire five years after the first therapeutic cannabis pharmacy sale unless the legislature votes to renew it.
Key Market Parameters
The program would be medical-only, requiring patients to have a qualifying condition, a physician certification, and a registration card. Qualifying conditions include cancer, multiple sclerosis, epilepsy, PTSD, Crohn's disease, sickle cell anemia, and several other debilitating diagnoses. Patients would be limited to a 14-day supply. No smoking, no home cultivation, no raw flower. All products must be processed, tested, and dispensed through the licensed pharmacy model.
Local control is built into the bill. Municipalities would have the authority to prohibit medical cannabis establishments in their jurisdictions or to regulate zoning, hours, and operational parameters. This means market access would vary by county and city, similar to how alcohol regulation works in many Southern states.
The program includes a five-year sunset provision. It would automatically expire five years after the first therapeutic cannabis pharmacy sale unless the legislature votes to renew it.
Why Early Planning Matters
New cannabis markets don't launch with immediate profitability. Operators who have studied other states know that the timeline between license award and revenue generation involves significant capital expenditure with no offsetting income. South Carolina's proposed structure adds specific considerations that make early financial planning essential.
What Operators Should Be Doing Now
South Carolina hasn't issued a single cannabis license yet. But if the Compassionate Care Act passes in 2026 or a subsequent session, the window between legislation and license applications will move faster than most people expect.
Here's what serious operators are doing in the meantime.
Building business plans based on the bill's actual structure
The Compassionate Care Act is detailed. The license types, caps, qualifying conditions, product restrictions, and local control provisions are all defined in the legislation. Business plans built on this framework will be more credible and more useful than generic cannabis business plans.
Identifying real estate
Facility location requirements, the 1,000-foot school buffer, county-level opt-in decisions, and zoning restrictions will all shape where operations can go. Operators who understand their target municipalities now will move faster when the time comes.
Establishing financial readiness
Merit-based application processes evaluate financial capacity. Having relationships with cannabis-specific financing partners, documented capital access, and realistic financial projections strengthens any application.
Monitoring the legislative session
The South Carolina General Assembly returns in January 2026. The Compassionate Care Act's fate in the House will determine whether the market opens.
FAQ's
South Carolina Cannabis Financing: Ready When the Market Is
South Carolina's cannabis market doesn't exist yet. But the legislative framework is more developed than most people realize, public support is strong, and the Compassionate Care Act has already demonstrated it can pass the Senate. When this market opens, the operators who planned early will have a meaningful advantage over those who waited.
FundCanna provides South Carolina cannabis business loans and financing to licensed operators across the country. We understand new markets, limited-license environments, and the capital requirements of building cannabis operations from the ground up. When South Carolina begins issuing licenses, we'll be here.
If you're planning for this market and want to understand your financing options, the conversation can start now.
Looking for a Cannabis Loan in South Carolina?
Our team is here to assist you with getting a Cannabis Loan.
Apply below and a member of the FundCanna team will be in touch right away.
PREVIOUS STATE
NEXT STATE
Follow Us
Explore